Using a large language model for post-deployment monitoring of FDA approved AI: pulmonary embolism detection use case

Artificial intelligence (AI) is increasingly integrated into clinical workflows. The performance of AI in production can diverge from initial evaluations. Post-deployment monitoring (PDM) remains a challenging ingredient of ongoing quality assurance once AI is deployed in clinical production.

Read the full article on jacr.org